David Cipolla - Search Results

Year	Number of Results
2004	1
2008	1
2010	2
2012	2
2013	4
2014	4
2015	2
2016	4
2017	1
2018	5
2019	5
2020	8
2021	10
2022	6
2023	6
2024	0

1

Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection.

Konicek DM, Plaunt AJ, Gharse S, Rose SJ, Dorfman A, Sabnis A, Baker T, Gauani H, Chun D, Li Z, Perkins WR, Cipolla D, Malinin VS. Konicek DM, et al. Among authors: cipolla d. Pharmaceutics. 2023 Aug 31;15(9):2250. doi: 10.3390/pharmaceutics15092250. Pharmaceutics. 2023. PMID: 37765219 Free PMC article.

2

Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis.

McDonald PP, Leifer FG, Basso J, Lasala D, Li D, Chen KJ, Zhang J, Perkins WR, Cipolla DC. McDonald PP, et al. Among authors: cipolla dc. Front Immunol. 2023 Aug 11;14:1231047. doi: 10.3389/fimmu.2023.1231047. eCollection 2023. Front Immunol. 2023. PMID: 37638021 Free PMC article.

3

The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.

Basso J, Chen KJ, Zhou Y, Mark L, LaSala D, Dorfman A, Atalla M, Chun D, Viramontes V, Chang C, Leifer F, McDonald PP, Cipolla DC. Basso J, et al. Among authors: cipolla dc. Front Pharmacol. 2023 Jul 19;14:1208780. doi: 10.3389/fphar.2023.1208780. eCollection 2023. Front Pharmacol. 2023. PMID: 37538173 Free PMC article.

4

Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.

Chen KJ, Zhang J, LaSala D, Basso J, Chun D, Zhou Y, McDonald PP, Perkins WR, Cipolla DC. Chen KJ, et al. Among authors: cipolla dc. Front Immunol. 2023 Jun 27;14:1185727. doi: 10.3389/fimmu.2023.1185727. eCollection 2023. Front Immunol. 2023. PMID: 37441081 Free PMC article.

5

Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.

Cipolla D, Zhang J, Korkmaz B, Chalmers JD, Basso J, Lasala D, Fernandez C, Teper A, Mange KC, Perkins WR, Sullivan EJ. Cipolla D, et al. Respir Res. 2023 May 17;24(1):133. doi: 10.1186/s12931-023-02444-z. Respir Res. 2023. PMID: 37198686 Free PMC article. Clinical Trial.

6

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder.

Gauani H, Baker T, Li Z, Malinin VS, Perkins WR, Sullivan EJ, Cipolla D. Gauani H, et al. Among authors: cipolla d. Pharmaceutics. 2023 Mar 14;15(3):934. doi: 10.3390/pharmaceutics15030934. Pharmaceutics. 2023. PMID: 36986795 Free PMC article.

7

Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

Corboz MR, Plaunt AJ, Malinin VS, Li Z, Gauani H, Chun D, Cipolla D, Perkins WR, Chapman RW. Corboz MR, et al. Among authors: cipolla d. J Pharmacol Exp Ther. 2022 Oct;383(1):103-116. doi: 10.1124/jpet.122.001174. Epub 2022 Aug 31. J Pharmacol Exp Ther. 2022. PMID: 36507843

8

Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections".

Plaunt AJ, Rose SJ, Kang JY, Chen KJ, LaSala D, Heckler RP, Dorfman A, Smith BT, Chun D, Viramontes V, Macaluso A, Li Z, Zhou Y, Mark L, Basso J, Leifer FG, Corboz MR, Chapman RW, Cipolla D, Perkins WR, Malinin VS, Konicek DM. Plaunt AJ, et al. Among authors: cipolla d. Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0125622. doi: 10.1128/aac.01256-22. Epub 2022 Oct 12. Antimicrob Agents Chemother. 2022. PMID: 36222535 Free PMC article. No abstract available.

9

An optimized method of extracting and quantifying active Neutrophil serine proteases from human whole blood cells.

Basso J, Zhang J, Lasala D, Rose SJ, Chen KJ, Cipolla D. Basso J, et al. Among authors: cipolla d. PLoS One. 2022 Aug 31;17(8):e0272575. doi: 10.1371/journal.pone.0272575. eCollection 2022. PLoS One. 2022. PMID: 36044421 Free PMC article.

10

Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery.

Plaunt AJ, Nguyen TL, Corboz MR, Malinin VS, Cipolla DC. Plaunt AJ, et al. Among authors: cipolla dc. Pharmaceutics. 2022 Jan 27;14(2):302. doi: 10.3390/pharmaceutics14020302. Pharmaceutics. 2022. PMID: 35214039 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year